Clinical Trial Update: Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a hemostatic and sealing agent to prevent seroma and other postoperative complications after axillary lymphadenectomy has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seroma

Drugs mentioned

• Unspecified hemostatic and sealing agent

Snippet

Sponsor: Hospital Universitario Virgen de la Arrixaca | Conditions: Seroma | Phase 4 | Status: COMPLETED